Skip to main content
. Author manuscript; available in PMC: 2021 Sep 1.
Published in final edited form as: Support Care Cancer. 2019 Dec 23;28(9):4097–4106. doi: 10.1007/s00520-019-05246-6

Table 3:

All-cause and cancer-specific mortality for patients with depressive symptoms prior to multiple myeloma diagnosis

All-Cause Mortality (total survival time=15,279 months, Events=363)

Covariate Person Years Events Crude Model (n=522) Minimally Adjusteda (n=522) Fully Adjustedb (n= 506, Events=354c)
HR 95% CI P HR 95% CI P HR 95% CI P

No depressive symptoms (reference) 903.33 254 1 - - 1 - - 1 - -
Depressive symptoms 369.92 109 1.04 0.83–1.30 0.74 1.04 0.82–1.30 0.76 1.01 0.79–1.29 0.94

Cancer Specific Mortality (total survival time=15,279 months, Events=247)

Covariate Person Years Events Crude Model (n=522) Minimally Adjusteda (n=522) Fully Adjustedb (n=506, Events=241c)
HR 95% CI P HR 95% CI P HR 95% CI P

No depressive symptoms (reference) 903.33 180 1 - - 1 - - 1 - -
Depressive symptoms 369.92 67 0.90 0.68–1.20 0.48 0.90 0.67–1.19 0.45 0.94 0.69–1.28 0.70
a:

adjusted for age, sex, race

b:

adjusted for sex, race, age, education, categories of number of comorbidities, marital status, PCS score (tertiles), year of diagnosis, smoking status

c:

Number of events for fully adjusted model was lower than crude and minimally adjusted models due to missing values in covariates included for adjustment.